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QepA is one of the genes that confer quinolone resistance in bacteria. The aim of this
study was to analyze the genetic structures of plasmids that carry a qepA3, a recently
discovered allele of qepA in Enterobacteriaceae clinical isolates. 656 non-redundant
Enterobacteriaceae clinical isolates were screened for the qepA3 gene and five isolates
were identified to carry the gene. Plasmids were isolated from these isolates and were
found to increase antibiotic resistance once the plasmids were transferred to Escherichia
coli. These plasmids were subcloned and sequenced to analyze the genetic structures
surrounding the qepA3 gene. The results showed that the five plasmids had different
genetic structures; two of the qepA3-containning isolates had either the blaCTX−M−14
or blaTEM 12 gene instead of the blaTEM 1 gene. The structures of both pKP3764 and− −
pECL3786 have not been previously described. In comparison with pHPA, there were a
number of changes in DNA sequences up- and down-stream of the qepA3 gene. These
findings provide better understanding of the genetic variations in qepA3 and would be
useful for diagnosis and control of quinolone resistance in clinical settings.
Keywords: plasmid-mediated quinolone resistance, QepA3 gene, recombinant plasmid, genetic structure, gene
variation
INTRODUCTION
According to past work (Cattoir et al., 2008), three mechanisms have been described for plasmid-
mediated quinolone resistance: qnr determinants (Mammeri et al., 2005; Nordmann and Poirel,
2005; Robicsek et al., 2006; Wang et al., 2011), aminoglycoside acetyltransferase aac(6′)- Ib-cr
(Robicsek et al., 2006), and the qepA and oqxAB eﬄux pump genes, which confer decreased
susceptibility to quinolones (Périchon et al., 2007; Yamane et al., 2007; Wong et al., 2015). The
qepA1 gene was ﬁrst investigated in 2007 by two groups from Japan and Belgium (Périchon et al.,
2007; Yamane et al., 2007). In 2008, the qepA2 was discovered by a French research group (Cattoir
et al., 2008). Currently, both the qepA1 and qepA2 genes have been reported worldwide (Liu
et al., 2008; Park et al., 2009; Guillard et al., 2011; Ruiz et al., 2012; Chen et al., 2014). Recently,
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we identiﬁed a new qepA allele qepA3 from in a Chinese patient
(GenBank with accession number JQ064560). Although the
human qepA has a fairly low prevalence in Korea (Kim et al., 2009;
Park et al., 2009), it is commonly found in Enterobacteriaceae
isolates from food- producing animals in China (Liu et al., 2008;
Ma et al., 2009; Chen et al., 2014). Therefore, more surveillance
is needed for Enterobacteriaceae harboring the qnr, aac(6′)-Ib-cr
and qepA.
In this study, we investigated the qepA gene in 656
Enterobacteriaceae isolates from hospitalized patients and only
13 isolates were found positive. This result conﬁrm that qepA
has low prevalence (1.98%) (0.91% for qepA1, 0.31% for qepA2
and 0.76% for qepA3 ) in patients of our area. However, ﬁve
isolates were determined to harbor novel qepA3 structures. These
structure were characterized to provide better understanding
of the gene for potential management of plasmid-mediated
antibiotic resistance.
MATERIALS AND METHODS
Bacterial Strains and Luria-Bertani (LB)
Agar Plates
Enterobacteriaceae isolates EC3157, EC3587, CD4359,
KP3764, and ECL3786 were identiﬁed using the Vitek 2
system (bioMérieux, France) according to the manufacturer’s
instructions. Escherichia coli isolates EC3157 and EC3587 were
isolated from the blood and sputum samples of ICU inpatients,
respectively. CD4359, an isolate of Citrobacter koseri, was
obtained from the sputum of an inpatient in Infection Unit,
while KP3764, an isolate of Klebsiella pneumoniae, was from
a blood sample of an ICU inpatient. ECL3786, an isolate of
Enterobacter cloacae, was from the chest wound secretions of a
cardiothoracic surgical inpatient. E. coli JM109 was used as the
host for cloning and an azide-resistant E. coli (strain J53) was
used as the recipient strain for conjugation experiments. The
LB1 agar medium for plasmid transformation contained 100 μL
of isopropyl β-D-1-thiogalactopyranoside (IPTG, 24 mg/mL),
200 μL of 5-bromo-4-chloro- 3-indolyl β-D-galactopyranoside
(X-Gal, 20 mg/mL) and 100 μL of ampicillin (Amp, 100 mg/mL)
in 100 mL medium. LB2 agar plates were used for conjugation
experiments and were supplemented with sodium azide
(150 μg/mL) and ciproﬂoxacin (0.25 μg/mL).
Susceptibility Testing
The minimum inhibitory concentrations (MICs) of eight
antimicrobial agents (nalidixic acid, oﬂoxacin, ciproﬂoxacin,
cefotaxime, ceftazidime, amikacin, and gentamicin) were
determined using the MicroScan microdilution panel (Scott,
USA) broth dilution method. E. coli ATCC 25922 and
Pseudomonas aeruginosa ATCC 27853 were used as the
controls. The results were interpreted according to the CLSI
guidelines (Clinical and Laboratory Standards Institute, 2014).
Plasmid Isolation and Sequence Analysis
Bacterial plasmid DNA was extracted using a plasmid extraction
kit (TaKaRa, Japan) according to the manufacturer’s instructions.
PCR ampliﬁcations were preformed using primers based on the
pHPA (Table 1, Yamane et al., 2007). PCR was run for 3 min
at 94◦C followed by 30 cycles of 1 min of denaturing at 94◦C
and annealing at 56.9◦C, with a ﬁnal elongation of 10 min at
72◦C on Life Veriti R© PCR machine (Invitrogen, USA). The total
reaction volume was 20 μl containing 4 μL 5X PCR buﬀer,
0.4 μL of 10 mM dNTPs, 1 μL each of 10 μM primers and
0.2 μL Polymerase, with nuclease-free water ﬁlled up to 20 μL,
and bacterial plasmids harboring the qepA gene as template. The
amplicons were digested with DraI and BamHI (TaKaRa, Japan),
ligated to linearized pMD19-T (TaKaRa, Japan), and transformed
into E. coli JM109 competent cells. Plasmids DNA from Amp
resistant colonies recovered on LB1 plate were sequenced.
Conjugation
The ﬁve isolates were conjugated with E. coli J53 as described
previously (Wang et al., 2003). In the conjugation experiments,
the isolates were used as donors and azide-resistant E. coli
J53 as the recipient strain by ﬁlter mating. Transconjugants
were selected on the LB2 agar plates. MICs for the donors,
transconjugants, and recipients were also measured as described
above.
RESULTS
Plasmid Isolation and Characterization
Plasmids were isolated from the ﬁve Enterobacteriaceae isolates
and separated on 0.7% agarose gel by gel electrophoresis.
Results showed that plasmids pKP3764, pECL3876, pEC3157,
pEC3587, and pCD4359 from isolates KP3764, pECL3876,
EC3157, EC3587, and CD4359 were estimated to be about 53 kb,
72 kb, 145, 152, and 168 kb, respectively (Figure 1A).
TABLE 1 | Primers used for PCR and sequencing.
Primer Sequence (5′-3′) Reference
tnpR F CGACACTGCCGATATGATCC Park et al., 2009
R CGGGCAATACTGAGCTGATG
TEM F ATAAAATTCTTGAAGACGAAA Lee et al., 2003
R GACAGTTACCAATGCTTAATC
rmtB F CCCAAACAGACCGTAGAGGC Lee et al., 2006
R CTCAAACTCGGCGGGCAAGC
qepA F AGCAGCGCGCTGAATCCA This study
R CGAACCCAGTGGACATAA
qepA
(sequencing)
F AGC AGCGCGCTGAATCCA This study
R CTTCCTGCCCGAGTA TCG TG
intI1 F GCCTTGCTGTTCTTCTACGG Han et al., 2004
R GATGCCTGCTTGTTCTACGG
tnpA F GGCGGGATCTGCTTGTAGAG Han et al., 2004
R CTCCGGAGATGTCTGGCTTACT
dfr2 F TTGGGCTTCACCAGAGTATCAAGTT Cattoir et al., 2008
R GCTGTGGACGGTGCCGCATGATTTG
CTX-M-14 F GAAAGAGAGTGCAACGGATG This study
R ATTGGAAAGGGTTCATCACC
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FIGURE 1 | Electrophoresis of plasmids isolated from clinical isolates and the recombinant plasmids used for sequence analysis. The left columns
indicate the DNA markers while the right column denote the plasmid sizes. (A) Lane M1, a λ DNA marker (Amersham Biosciences, USA); Lanes 1–5, plasmids
pKP3764, pECL3876, pEC3157, pEC3587, and pCD4359. (B) Lane M2, λ HindIII DNA marker (Amersham Biosciences, USA); Lanes 1–5, recombinant plasmids
pECD2, pECD4, pCDD2, pKPD1, and pECLD1.
The qep A-containing sequences in the ﬁve strains were
ampliﬁed, digested with DraI and/or BamHI and subcloned in
pMD19-T to generate recombinant plasmids pECD1, pECD2,
pECD3, pECD4, pCDD2, pKPD1, and pECLD1 (Figure 1B).
The inserts in these plasmids were sequenced and analyzed for
qep A and its ﬂanking structures (GenBank accession numbers
KR259130, KR259131, KR259132, KR259133, and KR259134,
Supplementary Material) (Figure 2). The results showed that in
addition to qepA3, which was present in all plasmids, the inserts
from pEC3157 and pCD4359 contained the blaCTX−M−14 and
rmtB genes; the inserts from pEC3587 had the blaTEM−12 gene;
inserts from all plasmids except pCD4359 had the truncated
dfr2 gene; the inserts from pCD4539 contained the blaTEM−1
and rmtB genes; the insert from pKPD1 and pECLD1 contained
truncated dfr2 gene. No other resistant genes were found in these
sequences.
Antibiotic Susceptibility
Through conjugation, the plasmids from the ﬁve isolates (donors)
were transferred to E. coli J53 (recipients). The MIC values
for cefotaxime and ceftazidime in the transconjugants with the
isolates EC3157, EC3587, and CD4359 were much higher than
those of the recipient E. coli J53 (Table 2). Similarly, the MIC
values for nalidixic acid, norﬂoxacin, oﬂoxacin, and ciproﬂoxacin
in the transconjugants with the ﬁve isolates were generally
higher than those of E. coli J53 (Table 2). Contrastingly, the
MIC values nalidixic acid, oﬂoxacin, ciproﬂoxacin, amikacin, and
gentamicin in the transconjugant involving the EC3157, EC3587,
CD4357, and ECL3786 were generally higher than those of E. coli
J53 (recipient) (Table 2). These results demonstrated that the
antibiotic resistant genes are located in the plasmids.
DISCUSSION
Previous studies have shown that quinolone and ﬂuoroquinolone
resistance genes in E. coli and Klebsiella isolates are located
on plasmids, which often carry other antimicrobial resistant
genes, and can be transferred to other strains by conjugation
or transformation (Ruiz et al., 2012). Since the discovery of
FIGURE 2 | Genetic structures surrounding the qepA3 gene in pEC3157, pEC3587, pCD4359, pKP3764, and pECL3786. The numbers in parentheses are
GenBank accession numbers; “ggatcc” and “tttaaa” indicate restriction sites;  (delta) denotes truncated gene; intI1-groEL denotes the truncated intI1 and groEL
fusion gene. The figures in the parentheses following the names of the plasmids denote the plasmid size.
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TABLE 2 | Minimum inhibitory concentrations of antimicrobial agents for donors, transconjugants, and their recipients.
Stain MIC (µg/mL)
NAL NOR OFL CIP CTX CAZ AMK GM
Donor
EC3157 128 8 4 2 128 4 64 128
EC3587 128 16 4 4 32 4 128 >128
CD4359 128 16 4 4 32 2 64 128
KP3764 128 8 4 2 0.25 0.25 0.50 0.125
ECL3786 32 8 2 2 0.125 0.125 64 128
Transconjugant
EC3157- Escherichia coli J53 8 2 1 0.50 8 1 16 32
EC3587- E. coli J53 16 4 1 1 4 1 32 64
CD4359- E. coli J53 16 4 1 1 4 1 16 64
KP3764- E. coli J53 16 2 1 0.50 0.125 0.125 0.50 0.063
ECL3786- E. coli J53 8 2 0.50 0.50 0.063 0.125 16 32
Recipient
E. coli J53 4 0.25 0.032 0.016 0.063 0.25 0.50 0.063
NAL, nalidixicacid; OFL, ofloxacin; CIP, ciprofloxacin; CTX, cefotaxime; CAZ, ceftazidime; AMK, amikacin; GEN, gentamicin; NOR, norfloxacin.
qepA1 and qepA2 in 2007 and 2008, the genetic environment
and location of the qepA genes in the plasmid pHPA have both
been well-established (Périchon et al., 2007; Yamane et al., 2007;
Cattoir et al., 2008). In this study, ﬁve Enterobacteriaceae isolates
carrying the qepA3 and surrounding genes were investigated,
and are found to have diﬀerent genetic structures (Figure 2)
surrounding qepA3.
The plasmid pCD4359 from isolate CD4359 showed a similar
structure to pHPA, except for the qepA allele and a truncated dfr2,
a gene closely related to vertebrate FGF-receptor. The plasmids
pEC3587 and pEC3157 were diﬀerent from pHPA, where
blaTEM−1 in pHPA was replaced by blaTEM−12 or blaCTX−M−14,
respectively (Figure 2). blaCTX−M−14,blaTEM−1, and blaTEM−12
code β-lactamase and are important determinants of drug
resistance. In addition, in pCD4359, there is an additionalintI1
downstream of the rmtB which confers high-level resistance to all
aminoglycoside and missing dfr2. The sequence between IS26
and tnpR was also truncated. Furthermore, rmtB or ISCR3C are
not linked with qepA3 directly in pKP3764 as reported previously
(Périchon et al., 2007; Yamane et al., 2007; Cattoir et al., 2008;
Kim et al., 2009; Rocha-Gracia et al., 2010; Cao et al., 2014).
In pEC3587, the blaTEM−12 gene took the place of blaTEM−1
and had a truncated dfr2 gene as compared with pHPA. These
results are also diﬀerent from previous reports (Périchon et al.,
2007; Yamane et al., 2007; Cattoir et al., 2008; Kim et al.,
2009; Rocha-Gracia et al., 2010; Cao et al., 2014). Surprisingly,
in pKP3764 there are three genes qepA3, truncated dfr2,
and truncated intI1-groEL fusion gene between the two IS26
insertions, while in pKP3764 and pECL3786, therefore are four
genes: rmtB, qepA3, truncated dfr2, and truncated intI1-groEL
fusion genes. To date, these genetic structures have not been
identiﬁed in previous studies (Kim et al., 2009; Rocha-Gracia
et al., 2010; Cao et al., 2014). Moreover, pKP3764 is the only
plasmid that does not contain the rmtB gene among the ﬁve
plasmids studied in this study. According to a previous report,
58.3% (28/48) of rmtB-positive E. coli isolates harbored the
qepA gene (Grape et al., 2005). Whether or not these results
suggest a strong link between qepA and rmtB remains to be
investigated. In these ﬁve genetic structures (Figure 2), the qepA3
gene and its downstream genes were nearly all identical except
for the truncated dfr2 deletion in pCD4359. After pEC3157 and
pEC3587 were digested by the DraI, the size of both products
were identical at approximate 6.2 kb. It should be noted that it is
also possible that the ISCR3C is not a stable link between ISCR3C
and the qepA gene.
QepA gene is a quinolone pump gene that confers resistance
to nalidixic acid and norﬂoxacin. Stains carrying the gene
may be resistant or sensitive to oﬂoxacin and ciproﬂoxacin
with increased MIC. In the conjugation experiments, we found
that E. coli cells with pEC3587 and pCD4359 were resistant
to penicillins and aminoglycoside antibiotics drugs such as
amikacin, gentamicin, gentamicin, and tobramycin. They were
tolerant or sensitive to oﬂoxacin and ciproﬂoxacin, but the
MICs were increased. These results indicate that there might
be synergistic eﬀect against antibiotics when the gepA, blaCTX-
M 14, and rmtB are present in the same plasmids, leading to
multidrug resistance.
Taken together, our works suggest that there are sequence
variations surrounding the qepA3 even if a limited number of
isolates are analyzed, and it is likely that more variations would
exist thatmay impact the resistance proﬁles, and subsequently the
clinical implications of the bacteria. More studies are needed to
link these structure variation to resistance proﬁles and potential
clinical outcomes.
CONCLUSION
The novel genetic structures surrounding the qepA3 gene have
been discovered in the isolates obtained from ﬁve patients in
China although the prevalence for the qepA allele in hospital
patients are low. One of the isolates is linked to the non-rmtB- or
non- ISCR3C- producing genetic structure in the qepA3 genetic
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environment. Moreover, the blaCTX−M−14 or blaTEM−12 genes are
found to be associated with the qepA3 gene in these structures
instead of the blaTEM−1 gene. These results provide new insight
into the variation in genetic environments of the qepA3 gene
and would be useful for further investigation of the clinical
implications in antibiotic resistance management.
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